|
TIAM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22044604925031E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.6621374255883E-15 |
| Normal-vs-Stage2 |
2.962400E-03 |
| Normal-vs-Stage3 |
1.19904086659517E-14 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.057800E-01 |
| Stage1-vs-Stage3 |
2.766200E-01 |
| Stage1-vs-Stage4 |
1.62570000017404E-07 |
| Stage2-vs-Stage3 |
8.297800E-02 |
| Stage2-vs-Stage4 |
2.915800E-03 |
| Stage3-vs-Stage4 |
2.996800E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
5.87390025508228E-10 |
| Normal-vs-Asian |
2.9739000151352E-10 |
| Caucasian-vs-AfricanAmerican |
3.678400E-01 |
| Caucasian-vs-Asian |
8.996600E-01 |
| AfricanAmerican-vs-Asian |
3.103000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.02450287037459E-11 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
3.569600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.11972669919669E-14 |
| Normal-vs-Age(41-60Yrs) |
1.72273306731086E-12 |
| Normal-vs-Age(61-80Yrs) |
1.89115390014649E-12 |
| Normal-vs-Age(81-100Yrs) |
1.481040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.480200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.357200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.856200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.822800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.347400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.459000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.742100E-02 |
| Classical-VS-Follicular |
5.647700E-02 |
| Classical-VS-Other |
5.727800E-01 |
| Classical-VS-Normal |
1.11022302462516E-16 |
| Tall-VS-Follicular |
5.981900E-03 |
| Tall-VS-Other |
3.587200E-01 |
| Tall-VS-Normal |
1.63613567139009E-12 |
| Follicular-VS-Other |
9.400600E-01 |
| Follicular-VS-Normal |
9.91179999999536E-05 |
| Other-VS-Normal |
1.432800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62625468647093E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
3.375200E-03 |
|
|
